Company: ZVRA
Filing Date: 2025-03-31
Form Type: PREC14A
Source: 0001193125-25-068746
Chunk: 76

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: PREC14A
Chunk 76
---
 the accompanying proxy to vote on such matters in accordance with their best judgment. By Order of the Board of Directors RAHSAAN W. THOMPSON Chief Legal Officer, Secretary and Compliance Officer [ ●], 2025

76

SUPPLEMENTAL INFORMATION REGARDING PARTICIPANTS IN THE COMPANY’S SOLICITATION OF PROXIES The Company, its directors (including our director nominees), as well as other persons who solicit proxies on its behalf, are considered to be “participants” in the Board’s solicitation of proxies from its stockholders in connection with the Annual Meeting under applicable regulations of the SEC. The following tables set forth the name, business address, present principal occupation and address of any corporation in which such employment is carried on of such “participants” in the Board’s solicitation of proxies. Directors and Nominees The present principal occupations or employment, and principal business of any corporation in which such occupation or employment is carried on, of the Company’s directors (including our director nominees) who are considered “participants” in the Board’s solicitation are set forth under the section above titled “Proposal 1— Election of Directors” of this proxy statement. The business address of each of the Company’s directors (including our director nominees) is c/o Zevra Therapeutics, Inc., 1180 Celebration Boulevard, Suite 103, Celebration, Florida 34747. The name, principal occupation and address of the organization of employment, of each of the Company’s directors (including our director nominees) are as follows:

| Name               |     | Principal Occupation or Employment                                                                                  |     | Business Address/Address of Organization of Principal Occupation of Employment              |
| Neil McFarlane     |     | President and Chief Executive Officer of Zevra Therapeutics, Inc.                                                   |     | Zevra Therapeutics, Inc., 1180 Celebration Boulevard, Suite 103, Celebration, Florida 34747 |
| Wendy Dixon, Ph.D. |     | Retired                                                                                                             |     | N/A                                                                                         |
| Tamara A. Favorito |     | Retired                                                                                                             |     | N/A                                                                                         |
| John B. Bode       |     | Executive Vice President, Chief Financial Officer and Chief Transformation Officer, Post Media Network Canada Corp. |     | 365 Bloor Street East Toronto, Ontario Canada M4W 3L4                                       |
| Douglas W. Calder  |     | President of Vycellix, Inc.                                                                                         |     | 3000 North Military